Breaking News Headlines Today

News from pharmtech.com

All of today’s top news stories from pharmtech.com. Get the full analysis behind how media bias impacts breaking news.

Overall, we’ve indexed 141 stories from pharmtech.com over the past 3 months.

We’ve assigned a media bias rating of Center to pharmtech.com. You can read more about our methodology here.

If you want to know if pharmtech.com is credible or reliable, look no further. We rank pharmtech.com as High factuality. Find out more about our methodology here.

Information about pharmtech.com

Where is pharmtech.com located?pharmtech.com's Website

Media Bias Ratings

Average Bias Rating:

Center

byAd Fontes Media

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top pharmtech.com News

Psychedelics · Florida

Local Experts Share the Dangers of the Recently Banned 7-OH

52% Center coverage: 45 sources

By Caleb Califano Click here for updates on this story STUART, Florida (WPBF) — Florida Attorney General James Uthmeier has announced an emergency rule making 7-hydroxymitragynine, also known as 7-OH, a Schedule I controlled substance. This means it is now illegal to sell, possess, or distribute the compound in the state. “We are taking emergency action now, because we see immediate danger,” Uthmeier said on Wednesday. He added that the deci…See the Story

Eli Lilly · United States

Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial, paving way for approval

66% Center coverage: 42 sources

See the Story

FDA · United States

US FDA moves to boost domestic drug manufacturing after Trump push

75% Center coverage: 12 sources

The U.S. Food and Drug Administration on Thursday announced a new program to speed up construction and review of drug manufacturing plants in the country to boost domestic drug supply.See the Story

AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.

89% Center coverage: 9 sources

New $195 million facility will further enhance AbbVie's active pharmaceutical ingredient (API) production capacity and capabilities in the U.S. Expansion is...Innovation · United States See the Story

Ousted FDA Vaccine Regulator Vinay Prasad Returns to Post

50% Center coverage: 10 sources

Vinay Prasad, the U.S. Food and Drug Administration's top vaccine regulator, is returning to his post less than two weeks after the White House had him ousted.Laura Loomer See the Story

In Europe, the Use of Titanium Dioxide in Drugs Will Continue

100% Center coverage: 1 sources

Based on an analysis done by the European Medicines Agency on the feasibility of alternatives, the European Commission maintains use of titanium dioxide in drug products.Read Article

Sustainability Becomes Essential: Green Manufacturing and Supply Chain Resilience in Bio/Pharma

100% Center coverage: 1 sources

Dave Miller, PhD, explains how environmental audits, waste reduction, and supply chain security are reshaping priorities in pharmaceutical manufacturing.See the Story

EMA Grants Orphan Designation to Rilzabrutinib for IgG4-Related Disease

100% Center coverage: 1 sources

Orphan status was granted based on Phase II data showing that treatment with rilzabrutinib reduced flares and improved markers while demonstrating consistent safety.Read Article

The Evolving Landscape of Rare Disease Pharmaceuticals (Part 1)

100% Center coverage: 1 sources

Drug development for rare diseases leverages genetic targeting and drives innovation and investment in pharmaceutical technology as well as precision medicine, according to Dan Williams, PhD, CEO, SynaptixBio.Innovation Read Article

Onshoring’s Unexpected Benefits: Quality, Efficiency, and Supply Chain Resilience

100% Center coverage: 1 sources

Dave Miller, PhD, discusses how shifting drug manufacturing to domestic CDMOs can improve quality, reduce rework, and enhance long-term efficiency.Read Article

The Importance for CDMOs of Partnering With a Sponsor’s Mindset

100% Center coverage: 1 sources

Dave Miller, PhD, explains how a development-first approach, scientific depth, and regulatory trust build lasting partnerships in the CDMO space.Read Article

News from pharmtech.com